BIOTECH

BIOTECH

Spexis announces USD $2.5 million capital commitment to support the upcoming Phase 3 ColiFin® studies

Spexis AG (SIX: SPEX), a clinical-stage biopharmaceutical company focused on macrocycle therapeutics for rare diseases...

Read more

BIOTECH

Spexis announces closing of capital commitment of USD 4.5 million from SPRIM Global Investments (SGI) to enable initiation of ColiFin® Phase 3 study

Spexis AG (SIX: SPEX), a clinical-stage biopharmaceutical company focused on rare diseases and oncology, today...

Read more

BIOTECH

AUM Biosciences, SCG Cell Therapy, Blood And Hello Health Disclose Updates

AUM Biosciences, a Singapore-headquartered biotech company focused on precision oncology therapeutics, allotted shares worth $11.8...

Read more

BIOTECH

STALICLA and Firefly Neuroscience enter Partnership Agreement for the Development of Electroencephalogram (EEG) as a Biomarker for Subgroups of Patients with ASD

STALICLA and Firefly Neuroscience enterPartnership Agreement for the Development of Electroencephalogram (EEG) asa Biomarker for Subgroups of Patients with...

Read more

BIOTECH

Jaguar Health Announces Initial Close in Private Placement Financing Round for Napo Therapeutics S.p.A.

This closing on funds from SPRIM Global Investments, a healthcare-focused international venture capital firm, was...

Read more